omega-n-methylarginine has been researched along with nabumetone in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (nabumetone) | Trials (nabumetone) | Recent Studies (post-2010) (nabumetone) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 393 | 105 | 60 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | nabumetone (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 5 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.868 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.998 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.868 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, S; Kawaguchi, AT; Min, KY; Ninomiya, I; Shimouchi, A; Shirai, M | 1 |
1 other study(ies) available for omega-n-methylarginine and nabumetone
| Article | Year |
|---|---|
Segmental differences in vasodilatation due to basal NO release in in vivo cat pulmonary vessels.
Topics: Angiography; Animals; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Cats; Enzyme Inhibitors; Hemodynamics; Nabumetone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Pulmonary Artery; Species Specificity; Vasodilation | 1999 |